hepatitis-b
Every record this desk has filed under hepatitis-b, newest first, each with the number of sources it can still show you.
FDA approves hepatitis B treatment for some adults already taking antiviral medicine
FDA approved Hibsago on October 20 for certain adults with chronic hepatitis B who do not have cirrhosis and meet treatment and laboratory requirements. Across two trials, 24% of treated patients qualified to stop their existing medicine. The injection carries a boxed warning for serious liver reactions and low platelet counts.
Also filed underhealthdrug-approvalspatient-safetyfda
A record appears here because it carries hepatitis-b in its own tags. If a record you expected is missing, it was filed under a different subject — the full list is on the topics index.